The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Histamine-1 receptor antagonism for treatment of insomnia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The evidence concerning antihistaminics in the treatment of insomnia is insufficient.”
From The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023 (2023) · cites this paper as Vande Griend & Anderson, 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of insomnia: what we know and what we still need to learn
Ohayon, M. M. (2002) · Sleep Medicine Reviews · doi:10.1053/smrv.2002.0186 · Cited by 3,743
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578
Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults
Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C., & Sateia, M. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27286 · Cited by 1,943
Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications
Stahl, S. M. (2021) · doi:10.1017/9781108975292 · Cited by 480
The Efficacy and Safety of Drug Treatments for Chronic Insomnia in Adults: A Meta-Analysis of RCTs
Buscemi, N., Vandermeer, B., Friesen, C., Bialy, L., Tubman, M., Ospina, M., Klassen, T. P., & Witmans, M. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0251-z · Cited by 448
A Review of the Evidence for the Efficacy and Safety of Trazodone in Insomnia
Mendelson, W. B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0409 · Cited by 308
Hajak, G., Rodenbeck, A., Voderholzer, U., Riemann, D., Cohrs, S., Hohagen, F., Berger, M., & Ruther, E. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0609 · Cited by 199
Morin, C. M., Koetter, U., Bastien, C., Ware, J. C., & Wooten, V. (2005) · Sleep · doi:10.1093/sleep/28.11.1465 · Cited by 190
Winokur, A., DeMartinis, N. A., McNally, D. P., Gary, E. M., Cormier, J. L., & Gary, K. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1013 · Cited by 165
Trimipramine in Primary Insomnia: Results of a Polysomnographic Double-Blind Controlled Study
Riemann, D., Voderholzer, U., Cohrs, S., Rodenbeck, A., Hajak, G., Rüther, E., Wiegand, M. H., Laakmann, G., Baghai, T., Fischer, W., et al. (2002) · Pharmacopsychiatry · doi:10.1055/s-2002-34119 · Cited by 145
Research works printed but not linked: 37
- Summers, 2006, Recent developments in the classification, evaluation, and treatment of insomnia, Chest, 130, 276, 10.1378/chest.130.1.276 · DOI
- Bhat, 2008, Pharmacotherapy of insomnia, Expert Opin Pharmacother, 9, 351, 10.1517/14656566.9.3.351 · DOI
- Ozminkowski, 2007, The direct and indirect costs of untreated insomnia in adults in the United States, Sleep, 30, 263, 10.1093/sleep/30.3.263 · DOI · Paper page
- Walsh, 1999, The direct economic costs of insomnia in the United States for 1995, Sleep, 22, S386
- Ramesh, 2004, Wakefulness-inducing effects of histamine in the basal forebrain of freely moving rats, Behav Brain Res, 152, 271, 10.1016/j.bbr.2003.10.031 · DOI
- Strecker, 2002, Extracellular histamine levels in the feline preoptic/anterior hypothalamic area during natural sleep-wakefulness and prolonged wakefulness: an in vivo microdialysis study, Neuroscience, 113, 663, 10.1016/S0306-4522(02)00158-6 · DOI
- Stahl, 2008, Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines, CNS Spectr, 13, 1027, 10.1017/S1092852900017089 · DOI · Paper page
- Glass, 2008, Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trial, J Clin Psychopharmacol, 28, 182, 10.1097/JCP.0b013e31816a9e4f · DOI
- Rickels, 1983, Diphenhydramine in insomniac family practice patients: a double-blind study, J Clin Pharmacol, 23, 234, 10.1002/j.1552-4604.1983.tb02730.x · DOI
- Meuleman, 1987, Evaluation of temazepam and diphenhydramine as hypnotics in a nursing-home population, Drug Intell Clin Pharm, 21, 716, 10.1177/106002808702100908 · DOI
- Sjoqvist, 1967, The hypnotic efficacy of doxylamine, Clin Pharmacol Ther, 8, 48, 10.1002/cpt196781part148 · doi:10.1002/cpt196781part148
- Winokur, 2000, Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study, Biol Psychiatry, 48, 75, 10.1016/S0006-3223(00)00882-9 · DOI · Paper page
- Cankurtaran, 2008, Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine, Support Care Cancer, 16, 1291, 10.1007/s00520-008-0425-1 · DOI
- Kim, 2008, Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression, Psychiatry Clin Neurosci, 62, 75, 10.1111/j.1440-1819.2007.01778.x · DOI
- Radhakishun, 2000, Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens, J Clin Psychopharmacol, 20, 531, 10.1097/00004714-200010000-00006 · DOI
- Ruigt, 1990, Effect of the antidepressant Org 3770 on human sleep, Eur J Clin Pharmacol, 38, 551, 10.1007/BF00278580 · DOI · Paper page
- Shen, 2006, Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine, Can J Psychiatry, 51, 27, 10.1177/070674370605100106 · DOI
- Schittecatte, 2002, Effects of mirtazapine on sleep polygraphic variables in major depression, Neuropsychobiology, 46, 197, 10.1159/000067812 · DOI
- Bon O, 2003, Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations, J Clin Psychopharmacol, 23, 377, 10.1097/01.jcp.0000085411.08426.d3 · DOI · Paper page
- Walsh, 1998, Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia, Human Psychopharmacol, 13, 191, 10.1002/(SICI)1099-1077(199804)13:3<191::AID-HUP972>3.0.CO;2-X · doi:10.1002/(sici)1099-1077(199804)13:3<191::aid-hup972>3.0.co;2-x
- Roth, 2011, Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacs, J Sleep Res, 20, 552, 10.1111/j.1365-2869.2011.00928.x · DOI
- Stein, 2011, Trazodone for sleep disturbance during methadone maintenance: a double-blind, placebo-controlled trial, Drug Alcohol Depend, 120, 65, 10.1016/j.drugalcdep.2011.06.026 · DOI
- Roth, 2007, Efficacy and safety of doxepin 1mg, 3mg, and 6mg in adults with primary insomnia, Sleep, 30, 1555, 10.1093/sleep/30.11.1555 · DOI · Paper page
- Scharf, 2008, Efficacy and safety of doxepin 1mg, 3mg, and 6mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study, J Clin Psychiatry, 69, 1557, 10.4088/JCP.v69n1005 · DOI
- Krystal, 2010, Efficacy and safety of doxepin 1mg and 3mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia, Sleep, 33, 1553, 10.1093/sleep/33.11.1553 · DOI · Paper page
- Roth, 2010, Efficacy and safety of doxepin 6mg in a model of transient insomnia, Sleep Med, 11, 843, 10.1016/j.sleep.2010.07.006 · DOI
- Krystal, 2011, Efficacy and safety of doxepin 3 and 6mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia, Sleep, 34, 1433
- Lankford, 2011, Efficacy and safety of doxepin 6mg in a four-week outpatient trial of elderly adults with chronic primary insomnia, Sleep Med, 13, 133, 10.1016/j.sleep.2011.09.006 · DOI
- Schweitzer, 1994, Sleepiness and performance during three-day administration of cetirizine or diphenhydramine, J Allergy Clin Immunol, 94, 716, 10.1016/0091-6749(94)90179-1 · DOI
- Manning, 1992, Central nervous system effects of meclizine and dimenhydrinate: evidence of acute tolerance to antihistamines, J Clin Pharmacol, 32, 996, 10.1002/j.1552-4604.1992.tb03801.x · DOI
- Bye, 1977, Evidence for tolerance to the central nervous effects of the histamine antagonist, triprolidine, in man, Eur J Clin Pharmacol, 12, 181, 10.1007/BF00609857 · DOI
- Levander, 1991, Peripheral antihistamine and central sedative effects of single and continuous oral doses of cetirizine and hydroxyzine, Eur J Clin Pharmacol, 41, 435, 10.1007/BF00626365 · DOI
- Monti, 2000, Histamine H1 receptor antagonists in the treatment of insomnia: is there a rational basis for use?, CNS Drugs, 13, 87, 10.2165/00023210-200013020-00002 · DOI
- Stimmel, 1997, Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects, Pharmacotherapy, 17, 10, 10.1002/j.1875-9114.1997.tb03674.x · DOI · Paper page
- Thase, 1999, Antidepressant treatment of the depressed patient with insomnia, J Clin Psychiatry, 60, 28
- Fox, 2009, Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly, Pharmacotherapy, 29, 383, 10.1592/phco.29.4.383 · DOI
- Roy, 2010, Prevalence and cost of insomnia in a state Medicaid fee-for-service population based on diagnostic codes and prescription utilization, Sleep Med, 11, 462, 10.1016/j.sleep.2009.09.012 · DOI
Cited by
European guideline for the diagnosis and treatment of insomnia
Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., Espie, C. A., Garcia‐Borreguero, D., Gjerstad, M., Gonçalves, M., et al. (2017) · Journal of Sleep Research · doi:10.1111/jsr.12594 · Cited by 2,049
The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023
Riemann, D., Espie, C. A., Altena, E., Arnardottir, E. S., Baglioni, C., Bassetti, C. L. A., Bastien, C., Berzina, N., Bjorvatn, B., Dikeos, D., et al. (2023) · Journal of Sleep Research · doi:10.1111/jsr.14035 · Cited by 834
“One systematic review stated that there were no high-quality randomised – controlled clinical studies demonstrating efficacy compared with placebo — concluding that the evidence for these drugs is small and there might also be a rapid development of tolerance (Vande Griend & Anderson, 2012).”
BackgroundReview of Safety and Efficacy of Sleep Medicines in Older Adults
Schroeck, J. L., Ford, J., Conway, E. L., Kurtzhalts, K. E., Gee, M. E., Vollmer, K. A., & Mergenhagen, K. A. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.09.010 · Cited by 373
Riemann, D., Baum, E., Cohrs, S., Crönlein, T., Hajak, G., Hertenstein, E., Klose, P., Langhorst, J., Mayer, G., Nissen, C., et al. (2017) · Somnologie · doi:10.1007/s11818-016-0097-x · Cited by 340
Pharmacological Treatment of Insomnia.
(2015) · PubMed Central · Cited by 109
Metadata
- Authors
- Vande Griend, J. P., & Anderson, S. L.
- Venue
- Journal of the American Pharmacists Association
- Publisher
- Elsevier BV
- Published
- 2012-11
- Volume
- 52
- Issue
- 6
- Pages
- e210-e219
- ISSN
- 1544-3191
- Cited by
- 79
- References
- 13
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Histamine-1 receptor antagonism for treatment of insomnia. https://app.cochat.ai/papers/10.1331/japha.2012.12051
- The paper
- Vande Griend, J. P., & Anderson, S. L. (2012). Histamine-1 receptor antagonism for treatment of insomnia. Journal of the American Pharmacists Association. https://doi.org/10.1331/japha.2012.12051
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.